Log In
BCIQ
Print this Print this
 

Trasylol, aprotinin

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionSerine protease inhibitor
Molecular Target Serine protease
Mechanism of ActionSerine protease inhibitor
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsReduce bleeding; Reduce post-operative hemorrhage
Regulatory Designation
PartnerNordic Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/23/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today